DM
ARNA

Deerfield Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Deerfield Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-398,194
Closed -$17.4M – 120
2018
Q2 		$17.4M Sell
398,194
-299,000
-43% -$12.9M 0.61% 62
2018
Q1 		$27.5M Sell
697,194
-825,372
-54% -$32.1M 0.95% 40
2017
Q4 		$51.7M Buy
1,522,566
+450,237
+42% +$12.8M 2.04% 14
2017
Q3 		$27.3M Buy
1,072,329
+655,600
+157% +$15M 1.23% 29
2017
Q2 		$7.03M Buy
+416,729
New +$5.71M 0.38% 64
2015
Q4 		– Sell
-464,088
Closed -$8.86M – 133
2015
Q3 		$8.86M Sell
464,088
-234,283
-34% -$7.96M 0.34% 74
2015
Q2 		$32.4M Sell
698,371
-224,567
-24% -$9.74M 1.08% 32
2015
Q1 		$40.3M Buy
922,938
+227,564
+33% +$10.6M 1.31% 19
2014
Q4 		$24.1M Buy
695,374
+110,574
+19% +$4.49M 0.87% 32
2014
Q3 		$24.5M Buy
584,800
+147,893
+34% +$6.6M 0.89% 37
2014
Q2 		$25.6M Buy
436,907
+315,249
+259% +$19.9M 1.03% 33
2014
Q1 		$7.66M Hold
121,658
– – 0.31% 77
2013
Q4 		$7.12M Hold
121,658
– – 0.37% 67
2013
Q3 		$6.41M Sell
121,658
-135,201
-53% -$9.08M 0.3% 75
2013
Q2 		$19.8M Buy
+256,859
New +$21M 0.93% 48

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management's ARNA Position: Q3 2018 in Review

Deerfield Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2018, closing a stake of 398,194 shares — an estimated $17.4M sold.

Deerfield Management first reported a position in ARNA in Q2 2013 and held it in 15 quarters. The position peaked at $51.7M in Q4 2017. 160 funds tracked by Wall St. Rank hold ARNA as of Q3 2018.

  • Deerfield Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • Deerfield Management sold 398,194 Arena Pharmaceuticals Inc shares in Q3 2018, an estimated $17.4M.
  • Deerfield Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Deerfield Management's Arena Pharmaceuticals Inc position peaked at $51.7M in Q4 2017.
  • 160 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2018.

Based on Deerfield Management's 13F filing for Q3 2018, filed 14 Nov 2018.